World’s first AI-designed small molecule drug completes Phase 2 clinical trial in China, administered to first patient
A Chinese company on Tuesday announced the advancement of the world's first small molecule drug candidate developed by generative artificial intelligence (AI), which has now progressed to Phase 2 clinical…